Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step down subsidiary of the Company.

Ref: SEC/SE/2026-27 Date: November 10, 2026 Corporate Relations Department Listing Department BSE Ltd. National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street, Plot No. C/1, G Block, Bandra Kurla Complex Mumbai- 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 500096 NSE Scrip Symbol: DABUR Ref: Submission of Information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step-down subsidiary of the Company Dear Sir/Madam, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), as amended from time to time, we wish to inform you that as per the information received by the Company, Atlanta Body and Health Products (Pty) Ltd. (“Atlanta”), a wholly owned subsidiary of Dermoviva Skin Essentials Inc. which is a wholly owned subsidiary of Dabur International Limited, which in-turn is a wholly owned subsidiary of Dabur India Limited has been liquidated/closed with effect from November 10, 2026. Accordingly, Atlanta stands dissolved and has ceased to be step-down wholly owned subsidiary of the Company. Requisite disclosure in terms of SEBI master circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure A. The above information shall also be made available on the Company's website at www.dabur.com. This is for your information and records. Thanking you, Yours faithfully For Dabur India Limited (Ashok Kumar Jain) Group Company Secretary and Chief Compliance Officer Encl: A/a DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi – 110 002, Tel.: +91 11 71206000 Regd. Office: 8/3, Asaf Ali Road, New Delhi – 110 002 (India) CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com Website: www.dabur.com Annexure-A Details as required to be disclosed under Regulation 30 of the SEBI LODR Regulations, read with SEBI master circular dated January 30, 2026 S. No. Particulars Details 1. the amount and percentage of the turnover or revenue or Nil income and net worth contributed by such unit or division or undertaking or subsidiary or associate company of the listed entity during the last financial year 2. date on which the agreement for sale has been entered Atlanta stands liquidated as on into; November 10, 2026 3. the expected date of completion of sale/disposal; 4. consideration received from such sale/disposal; 5. brief details of buyers and whether any of the buyers belong to the promoter/ promoter group/group companies. If yes, Not applicable, as the closure of details thereof Atlanta was carried out by way 6. whether the transaction would fall within related party of voluntary liquidation/strike transactions? If yes, whether the same is done at “arm’s off. length”; 7. whether the sale, lease or disposal of the undertaking is outside Scheme of Arrangement? If yes, details of the same including compliance with regulation 37A of LODR Regulations. 8. additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale. DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi – 110 002, Tel.: +91 11 71206000 Regd. Office: 8/3, Asaf Ali Road, New Delhi – 110 002 (India) CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com Website: www.dabur.com